Competitive landscape

View All

Delveinsight
What are your views on Gene Therapy?

"We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson. This fate that Watson is talking about is contained in our genes, and deals with a new technique, GENE THERAPY. Gene therapy is an innovative way to fix genetic problem from th...

Find More

Delveinsight
Antibody-Drug Conjugate Market Outlook, 2015 Report in Market Now!

Launch of DelveInsight’s Antibody-Drug Conjugate Report DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-dr...

Find More

Delveinsight
DelveInsight’s Gene Therapy Reports: Launched

Immense Growth Potential in the Gene Therapy Market! DelveInsight has launched its Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape”. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opin...

Find More

Delveinsight
A CRISPR-Cas9 approach for Gene Therapy: The Hot New R&D Field!

Only a hundred and fifty years have passed since Gregor Mendel’s discovery of simple Mendelian inheritance. In a remarkably short amount of time humans have achieved such impressive feats as sequencing the entire human genome and gaining understanding of the causes of most genetic disease. Now that researchers have ...

Find More

Delveinsight
Are you ready to embrace Gene Therapy?

Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...

Find More

Delveinsight
DelveInsight’s Ophthalmologic disorders based Gene Therapy Reports

Gene Therapy: Eye for the cure! Recent technical advances have led to the demonstration of the molecular basis of various ocular diseases. Gene transfer into ocular tissues has been demonstrated with growing functional success and may develop into a new therapeutic tool for clinical ophthalmology.  There are pr...

Find More

Delveinsight
DelveInsight’s Hematological disorders based Gene Therapy Reports

Gene Therapy to “target” Hematological disorders! About Hematological disorders Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (h...

Find More

Delveinsight
DelveInsight’s Respiratory disorders based Gene Therapy Reports

Gene Therapy’s “expanding” role in Respiratory disorders! About Respiratory disorders Respiratory disorders encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles...

Find More

Delveinsight
DelveInsight’s Immunology based Gene Therapy Reports

Gene Therapy: The “Hope” for Immunologic disorders! About Immunologic disorders Immunological disorders are a dysfunction of the immune system. These disorders cause abnormally low activity or overactivity of the immune system. In cases of immune system overactivity, the body attacks and damages its own tissues. T...

Find More

Delveinsight
DelveInsight’s Cardiovascular disorders based Gene Therapy Reports

Gene Therapy to “heal” Cardiovascular disorders! Coronary artery disease, heart failure, and cardiac arrhythmias are major causes of morbidity and mortality in the developed countries. Pharmacologic drugs and device therapies have multiple limitations, and there exists an unmet need for improved clinical outcomes ...

Find More